Cytonics Corp is raising up to $5M on Dealmaker Securities LLC in common stock at $4 each; in its filing revenue was $260K and it had 1 employee (Form C-U, 2026-08-07).
Cytonics Corp filed a Regulation Crowdfunding offering with the SEC through Dealmaker Securities LLC, with a target of $10K and a maximum of $5M. As of November 6, 2026, the offering is open, with a deadline of February 24, 2027. The company gives its address as Jupiter, FL (Form C/A, May 1, 2026).
Sell to companies like Cytonics Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Progress update · C-U
- · What it is: Annual report · C-AR
- · Intermediary: Dealmaker Securities LLC · Target: $10K · Maximum: $5M · Deadline: 2027-02-24 · Security: Common Stock · C/A
- · What it is: Progress update · C-U
- · Intermediary: Dealmaker Securities LLC · Target: $10K · Maximum: $5M · Deadline: 2027-02-24 · Security: Common Stock · C
Cytonics Corp, based in Jupiter, FL, filed 3 Regulation Crowdfunding offering filings with the SEC, the latest on 2026-05-01, raising through Dealmaker Securities LLC. It set a target of $10K and will accept up to $5M. The security offered is common stock at $4 each. As of its filings the offering is open, with a deadline of 2027-02-24. 9 filings in this family are on record for the company.
Terms at a glance
| Target | $10K |
| Maximum it will accept | $5M |
| Security | Common Stock |
| Price per unit | $4 |
| Units at the target | 2,450 |
| Raise above the target | accepted, other |
| Deadline | 2027-02-24 |
| Raising through | Dealmaker Securities LLC |
| What the portal is paid, as filed | The Company will pay DealMaker Securities LLC an 8.5% cash commission fee based on the dollar amount of the Securities sold in the Offering. There is also a one-time $13,750 fee and $12,000 monthly fee payable to DealMaker Securities and/or its affiliates. |
Check before you invest in Cytonics Corp: who signed the filing and its own figures, free.
Free to see. No signup.
Want the whole picture on Cytonics Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cytonics Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cytonics Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
The filing does not state a company valuation or a minimum investment; the offering page on Dealmaker Securities LLC shows those. Check both before you invest.
Offering filings
| Filed | Intermediary | Target | Maximum | Deadline | Security | Filing |
|---|---|---|---|---|---|---|
| 2026-05-01 | Dealmaker Securities LLC | $10K | $5M | 2027-02-24 | Common Stock | C/A |
| 2026-02-24 | Dealmaker Securities LLC | $10K | $5M | 2027-02-24 | Common Stock | C |
| 2024-08-12 | Startengine Primary LLC | $10K | $1000K | 2024-08-25 | Series C Preferred Stock | C/A |
Financials the company filed
Figures from the C-U filed 2026-08-07, as the company reported them.
| As filed | Most recent fiscal year | Prior fiscal year |
|---|---|---|
| Revenue | $260K | $307K |
| Net income | -$8.59M | -$4.53M |
| Total assets | $2.41M | $2.78M |
| Cash and equivalents | $2.15M | |
| Short-term debt | $0 | |
| Long-term debt | $0 |
Employees at filing: 1.
Revenue went from $307K to $260K (-15%). Net loss was $8.59M, against a loss of $4.53M the year before. It reported $2.15M in cash and $0 in debt. These are the company's own figures from the Form C-U filed 2026-08-07.
Progress updates
2026-08-07, C-U:
The Offering ended early on August 6, 2026, having closed on funds totaling $2,815,859.65, although final accounting has yet to take place.
2026-03-25, C-U:
The Offering successfully reached its Target Offering Amount on March 21, 2026, having closed on $329,362.22 of funds.
2024-09-17, C-U:
At the close of the offering, the issuer closed on $549,174.95 and 346,626 number of securities.
People who signed the filing
- Anjun (Joey) Bose, Director, CEO, Principal Executive Officer, Principal Accounting and Financial Officer
- Gaetano Scuderi, Director
- Gordon Ramseier, Director
- Tracy Goeken, Director
Every filing
| Filed | What it is | Filing |
|---|---|---|
| 2026-08-07 | Progress update | C-U |
| 2026-05-04 | Annual report | C-AR |
| 2026-05-01 | Offering amended | C/A |
| 2026-03-25 | Progress update | C-U |
| 2026-02-24 | Offering | C |
| 2026-02-10 | Annual report | C-AR |
| 2025-04-30 | Annual report | C-AR |
| 2024-09-17 | Progress update | C-U |
| 2024-08-12 | Offering amended | C/A |
What to check before investing
- Read the offering page on Dealmaker Securities LLC: it states the valuation or cap and the minimum investment, which the SEC filing does not.
- Compare the terms above with the numbers: what does the price imply against revenue of $260K?
- Look at who signed the filing and what else they have run (the founder Snapshot below).
- Check the deadline and what happens if the target is missed.
- You cannot easily sell a crowdfunding security; invest only what you can leave tied up.
A crowdfunding round is won in public. FoxPlug turns your commits, deploys and releases into the posts and visuals that keep the story moving while the offering is open.
Build your launch kitRun a Snapshot on Anjun (Joey) Bose: other companies, roles and the record behind them. Order Full Report from there if you need more.
Snapshot the foundersTools for this story
Each opens in a new tab, filled in for Cytonics Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A company raising money from the public under Regulation Crowdfunding has to file with the SEC before the offering opens, and has to raise through a single registered intermediary: a funding portal or a broker-dealer. The first filing, Form C, states how much the company is trying to raise, the most it will accept, the deadline, the security and its price, the intermediary and what the intermediary is paid, and two years of the company's own financial figures.
After that the company files amendments when terms change, progress updates as the raise moves, and an annual report each year until it stops reporting. Every row here is one of those filings, linked to the filing itself, so each figure can be checked at the source. Figures are exactly as the company filed them; where a filing leaves a field blank, so does this page. Nothing here is investment advice, and a filing is the company's own statement, not a verification of it.